CytomX Therapeutics, Inc.

Q2 2018 13F Holders

Symbol
CTMX
CUSIP
23284F105
Type
Equity
Class
COM
Num filers
144
Total reported value, excl. options
$741M
Manager Report Date Value ($000) Shares